Coronavirus (COVID-19) updates for UC San Diego Health patients and visitors. Learn More

Menu
Search

How to Reset a Diseased Cell

 

May 01, 2015  |  

In proof-of-concept experiments, researchers at University of California, San Diego School of Medicine demonstrate the ability to tune medically relevant cell behaviors by manipulating a key hub in cell communication networks. The manipulation of this communication node, reported in this week’s issue of Proceedings of the National Academy of Sciences, makes it possible to reprogram large parts of a cell’s signaling network instead of targeting only a single receptor or cell signaling pathway.

The potential clinical value of the basic science discovery is the ability to eventually develop techniques – drugs or gene therapy approaches, for example – that could slow or reverse the progression of diseases, such as cancer, which are driven by abnormal cell signaling along multiple upstream pathways.

“Our study shows the feasibility of targeting a hub in the cell signaling network to reset aberrant cell signaling from multiple pathways and receptors,” said senior author Pradipta Ghosh, MD, an associate professor of medicine.

Specifically, the UC San Diego team has engineered two peptides – protein fragments – to either turn on or turn off activity in a family of proteins called G proteins.

G protein-coupled receptors, commonly found on the surface of cells, enable cells to sense and respond to what is happening around them. About 30 percent of all prescription drugs affect cells via G protein-coupled receptors.

Researchers, including members of the UC San Diego team, recently discovered that G proteins can also be activated inside cells – not just on cell membranes – by other receptors, including a protein called GIV. Its activity is implicated in cancer metastasis and other disease states. Both the “on” and “off” peptides were made from a piece of the GIV protein receptor.

In a series of cell culture experiments, the “on” peptides were shown to accelerate cells’ ability to migrate after scratch-wounding, a process linked to wound healing. The “off” peptide, in contrast, reduced the aggressiveness of cancer cells and reduced the production of collagen by cells associated with liver fibrosis. In experiments with mice, the topical application of the “on” peptides helped skin wounds heal faster.

“The takeaway is that we can begin to tap an emerging new paradigm of G protein signaling,” Ghosh said. 

Co-authors include Gary Ma, Nicolas Aznar, Nicholas Kalogriopoulos, Krishna Middle, Immaculada Lopez-Sanchez, Emi Sato, and Ying Dunkel, UC San Diego; and Richard Gallo, UC San Diego and Veterans Affairs San Diego Healthcare System.

The research was funded, in part, by National Institutes of Health (grants CA160911, DK099226, R01AI052453 and AR052728), American Cancer Society, Burroughs Wellcome Fund, Dorris Duke Charitable Foundation, and American Heart Association.


​Care at UC San Diego Health System

Cancer



Media Contact

Scott LaFee
858-249-0456
slafee@health.ucsd.edu

Share This Article


Related News

7/29/2020
Researchers at UC San Diego School of Medicine are among the contributors to a package of 10 studies in the journal Nature, describing the latest results from the ongoing Encyclopedia of DNA Elements ...
2/6/2020
Researchers from University of California San Diego School of Medicine have defined the most detailed list of genetic fingerprints of DNA-damaging processes that drive cancer development to date.
1/28/2020
University of California San Diego School of Medicine researchers created a new type of brain cancer model for glioblastoma using stem cells, CRISPR and gene sequencing.
11/20/2019
UC San Diego researchers describe how circular extrachromosomal DNA in cancer cells boosts aggressiveness and resistance to therapies.



Follow Us